PeerVoice

PeerVoice Heart & Lung Audio

Science EN ↓ Odcinki: 72

PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Heart & Lung that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: www.peervoice.com

Autor

PeerVoice

Kategoria

Science

Strona podcastu

www.peervoice.com

Ostatni odcinek

9 lis 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android 10 mln+ pobrań · ocena 4,7+ iOS wkrótce

Odcinki

Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes 23.03.2023

Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes

Franco Cecchi, MD - Improving Collaborative Care for HCM: Tips and Tricks From the Multidisciplinary Cardiology Team 14.02.2023

Franco Cecchi, MD - Improving Collaborative Care for HCM: Tips and Tricks From the Multidisciplinary Cardiology Team

Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections 06.01.2023

Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections

Perry Elliott, MD, FRCP, FESC - Thickening of the Heart, and HCM Is to Blame: A Call for Improved Recognition, Diagnosis, and Management of HCM 29.12.2022

Perry Elliott, MD, FRCP, FESC - Thickening of the Heart, and HCM Is to Blame: A Call for Improved Recognition, Diagnosis, and Management of HCM

Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC 14.12.2022

Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC

Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure 06.12.2022

Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure

Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes 05.12.2022

Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes

Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered 14.11.2022

Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered

Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022 27.10.2022

Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022

Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure 20.10.2022

Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure

Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice 03.10.2022

Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC 29.09.2022

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC

Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC 20.09.2022

Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC

New Biomarkers, New Targets in Advanced NSCLC 17.08.2022

New Biomarkers, New Targets in Advanced NSCLC

Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC 11.07.2022

Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC

Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022 30.06.2022

Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022

Evolving Clinical Management of the Hospitalised COVID-19 Patient 30.05.2022

Evolving Clinical Management of the Hospitalised COVID-19 Patient

Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World 24.05.2022

Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World

Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID 18.05.2022

Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID

Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale is Compromised 18.05.2022

Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale is Compromised

Managing Complex Patients Hospitalized Due to COVID-19: Cases in Practice 16.05.2022

Managing Complex Patients Hospitalized Due to COVID-19: Cases in Practice

Biologics in Asthma and Nasal Polyposis: Decision-Making in Practice 29.03.2022

Biologics in Asthma and Nasal Polyposis: Decision-Making in Practice

Słuchaj podcastu PeerVoice Heart & Lung Audio w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS